Regional myocardial effects of intracoronary bradykinin in conscious dogs

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 3 41-3, 1997, Pages

  Houel, Rémi ^a   Su, Jinbo ^a   Barbe, Fabrice ^a   Choussat, Rémi ^a   Crozatier, Bertrand ^a   Hittinger, Luc ^a  

^a INSERM   (France)

Author keywords

angiotensin converting enzyme inhibition; coronary circulation; regional function

Indexed keywords

ACETYLCHOLINE; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; GLYCERYL TRINITRATE; ICATIBANT;

ACUTE HEART INFARCTION; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; HEART PROTECTION; HEMODYNAMIC PARAMETERS; INTRACORONARY INFUSION; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

EID: 0030909415     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.3.h1266     Document Type: Article

References (33)

1. Baker, D. G., H. M. Coleridge, J. C. G. Coleridge, and T. Nerdrum. Search for a cardiac nociceptor: stimulation by bradykinin of sympathetic afferent nerve endings in the heart of the cat. J. Physiol. (Lond.) 306: 519-536, 1980.
2. Barron, K. W., and V. S. Bishop. The influence of vagal afferents on the left ventricular contractile response to intracoronary administration of catecholamines in the conscious dog. Circ. Res. 49: 159-169, 1981.
3. Canty, J. M. Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unanesthetized dog. Circ. Res. 63: 821-836, 1988.
4. Cherry, P. D., R. F. Furchgott, J. V. Zawadzki, and D. Jothianandan. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc. Natl. Acad. Sci. USA 79: 2106-2110, 1982.
5. Ehring, T., D. Baumgart, M. Krajcar, M. Hümmelgen, S. Kompa, and G. Heusch. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation 90: 1368-1385, 1994.
6. Félétou, M., M. Germain, and B. Teisseire. Converting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H839-H845, 1992.
7. Freeman, G. L., M. M. LeWinter, E. R. L., and J. W. Covell. Relationship between myocardial fiber direction and segmental shortening in the midwall of the canine left ventricle. Circ. Res. 56: 31-39, 1985.
8. Gaasch, W. H., and S. A. Bernard. The effect of acute changes in coronary blood flow on left ventricular end-diastolic wall thickness. An echocardiography study. Circulation 56: 593-598, 1977.
9. Gohlke, P., W. Linz, B. A. Schölkens, I. Kuwer, S. Bartenbach, A. Schnell, and T. Unger. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 23: 411-418, 1994.
10. Hecker, M., I. Pörsti, A. T. Bara, and R. Busse. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level. Br. J. Pharmacol. 111: 238-244, 1994.
11. Kaufman, M. P., D. G. Baker, H. M. Coleridge, and J. C. G. Coleridge. Stimulation by bradykinin of afferent vagal C-fibers with chemosensitive endings in the heart and aorta of the dog. Circ. Res. 46: 476-484, 1980.
12. Kimura, E., K. Hashimoto, S. Furukawa, and H. Hayakawa. Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. Am. Heart J. 85: 635-647, 1973.
13. Kitakaze, M., T. Minamino, K. Node, K. Komamura, Y. Shinzaki, H. Mori, H. Kosaka, M. Inoue, M. Hori, and T. Kamada. Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs. Circulation 92: 950-961, 1995.
14. Kuga, T., K. Egashira, M. Mohri, H. Tsutsui, Y. Harasawa, Y. Urabe, S. Ando, H. Shimokawa, and A. Takeshita. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. Circulation 92: 183-189, 1995.
15. Linz, W., G. Wiemer, P. Gohlke, T. Unger, and B. A. Schölkens. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev. 47: 25-49, 1995.
16. Lochner, W., and J. R. Parratt. A comparison of the effects of locally and systemically administered kinins on coronary blood flow and myocardial metabolism. Br. J. Pharmacol. 26: 17-26, 1966.
17. Lombardi, F., P. Della Bella, R. Casati, and A. Malliani. Effects of intracoronary administration of bradykinin on the impulse activity of afferent sympathetic unmyelinated fibers with left ventricular endings in the cat. Circ. Res. 48: 68-75, 1981.
18. Maxwell, G. M., R. B. Elliot, and G. M. Kneebone. Effects of bradykinin on the systemic and coronary vascular bed of the intact dog. Circ. Res. 10: 359-363, 1962.
19. Minshall, R. D., F. Nakamura, R. P. Becker, and S. F. Rabito. Characterization of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes. Circ. Res. 76: 773-780, 1995.
20. Minshall, R. D., V. P. Yelamanchi, A. Djokovic, D. J. Miletich, E. G. Erdös, S. F. Rabito, and S. M. Vogel. Importance of sympathetic innervation in the positive inotropic effects of bradykinin and Ramiprilat. Circ. Res. 74: 441-447, 1994.
21. Mombouli, J. V., S. Illiano, T. Nagao, T. Scott-Burden, and P. M. Vanhoutte. Potentiation of endothelium-dependent relaxation to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ. Res. 71: 137-144, 1992.
22. Mombouli, J. V., and P. M. Vanhoutte. Kinins and endothelial control of vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. 35: 679-705, 1995.
23. Munch, P. A., and J. C. Longhurst. Bradykinin increases myocardial contractility: relation to the Gregg phenomenon. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R1095-R1103, 1991.
24. Pagani, M., P. Pizzinelli, R. Furlan, S. Guzzetti, O. Rimoldi, G. Sandrone, and A. Malliani. Analysis of the pressor sympathetic reflex produced by intracoronary injections of bradykinin in conscious dogs. Circ. Res. 56: 175-183, 1985.
25. Parent, R., R. Paré, and M. Lavallée. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H10-H16, 1992.
26. Pelc, L. R., G. J. Gross, and D. C. Warltier. Mechanism of coronary vasodilation produced by bradykinin. Circulation 83: 2048-2056, 1991.
27. Pitt, B., J. Mason, C. R. Conti, and R. W. Colman. Activation of the plasma kallicrein system during myocardial ischemia. Adv. Exp. Med. Biol. 8: 403-410, 1970.
28. Regoli, D., and J. Barabe. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32: 1-46, 1980.
29. Sasayama, S., D. Franklin, J. J. Ross, W. S. Kemper, and D. McKown. Dynamic changes in left ventricular wall thickness and their use in analyzing cardiac function in the conscious dog. Am. J. Cardiol. 38: 870-879, 1976.
30. Schulz, R., B. D. Guth, and G. Heusch. No effect of coronary perfusion on regional myocardial function within the autoregulatory range in pigs. Circulation 83: 1390-1403, 1991.
31. Scicli, A. G. Increases in cardiac kinins as a new mechanism to protect the heart. Hypertension 23: 419-421, 1994.
32. Su, J. B., L. Hittinger, P. Le Franc, and B. Crozatier. Limited left ventricular inotropic response to exercise in early phase of pressure overload in dogs. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1011-H1016, 1992.
33. Toda, N., K. Bian, T. Akiba, and T. Okamura. Heterogeneity in mechanisms of bradykinin action in canine isolated blood vessels. Eur. J. Pharmacol. 135: 321-329, 1987.